|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/00 |
| (11) | Number of the document | 2836508 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13714303.8 |
| Date of filing the European patent application | 2013-04-05 | |
| (97) | Date of publication of the European application | 2015-02-18 |
| (45) | Date of publication and mention of the grant of the patent | 2016-06-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/057196 |
| Date | 2013-04-05 |
| (87) | Number | WO 2013/153000 |
| Date | 2013-10-17 |
| (30) | Number | Date | Country code |
| 12163730 | 2012-04-11 | EP | |
| 201261624463 P | 2012-04-16 | US | |
| 13157748 | 2013-03-05 | EP | |
| 201361778554 P | 2013-03-13 | US |
| (72) |
NAVER, Helle, DK
SCHLEIN, Morten, DK
STEENSGAARD, Dorte Bjerre, DK
PETTERSON, Ingrid Vivika, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | INSULIN FORMULATIONS |
| INSULIN FORMULATIONS |